1997
DOI: 10.1002/(sici)1096-9098(199703)64:3<231::aid-jso10>3.0.co;2-7
|View full text |Cite
|
Sign up to set email alerts
|

Survival benefit of extended D2 resection for proximal gastric cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
13
0
1

Year Published

2000
2000
2009
2009

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 19 publications
1
13
0
1
Order By: Relevance
“…Curative resection was the determining factor to improve the 5-year survival in this type of tumor [31] . Although D2 radical resection for patients with cancer of gastric cardia and fundus is widely accepted [32] , how many lymph nodes should be removed to accurately predict clinical outcome has not been determined. Barbour et al [33] suggested patients with Siewert types Ⅱ and Ⅲ adenocarcinoma of the GEJ should undergo adequate lymphadenectomy to permit examination of ≥ 15 lymph nodes allowing the accurate identification of prognostic variables.…”
Section: Discussionmentioning
confidence: 99%
“…Curative resection was the determining factor to improve the 5-year survival in this type of tumor [31] . Although D2 radical resection for patients with cancer of gastric cardia and fundus is widely accepted [32] , how many lymph nodes should be removed to accurately predict clinical outcome has not been determined. Barbour et al [33] suggested patients with Siewert types Ⅱ and Ⅲ adenocarcinoma of the GEJ should undergo adequate lymphadenectomy to permit examination of ≥ 15 lymph nodes allowing the accurate identification of prognostic variables.…”
Section: Discussionmentioning
confidence: 99%
“…Ultimately, high-risk stage I patients become low-risk stage II patients, which leads to the erroneous observation that extended lymphadenectomy enhances the survival of patients with stage I and II gastric cancer. [23][24][25] Proponents of the D2 resection question the design and setting of the two randomized D1/D2 European trials. Since 1962, Japanese surgeons have been performing extensive D2 and D3 resections for gastric cancer with operative mortality rates of less than 3%.…”
Section: Discussionmentioning
confidence: 99%
“…Lymph node metastasis is the primary prognostic factor in gastric cancer [1][2][3][4][5] and systematic extensive lymph node dissection has a favorable effect on survival [2,[6][7][8][9][10][11][12][13][14][15][16]. Still now, the extent of nodal involvement and the number of metastasized lymph node are the focus for determining a patient's prognosis.…”
Section: Introductionmentioning
confidence: 99%